CYP1B1 and esophageal squamous cell carcinoma: ESCC patients with higher mRNA levels of MMS22L (HR = 0.33; CI: 0.14−0.75; logrank p = 0.0052) and MUC13 (HR = 0.37; CI: 0.14−0.96; logrank p = 0.033) had higher OS (Figures 3A, B), and ESCC patients with lower mRNA levels of VAPA (HR = 2.32; CI: 1.04−5.17; logrank p = 0.035), CYP1B1 (HR = 2.67; CI: 1.02−6.97; logrank p = 0.039), and UBC (HR = 2.26; CI: 1.03−4.96; logrank p = 0.038) had higher OS (Figures 3C–E), while the mRNA expression of UGDH, MME and CUL13 were not associated with ESCC patient survival (Figures 3F–H).